| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Long QT Syndrome | 20 | 2021 | 473 | 2.640 |
Why?
|
| Death, Sudden, Cardiac | 31 | 2022 | 1567 | 2.500 |
Why?
|
| Arrhythmias, Cardiac | 25 | 2022 | 2257 | 2.190 |
Why?
|
| Polymorphism, Single Nucleotide | 110 | 2024 | 16036 | 2.090 |
Why?
|
| Blood Pressure | 45 | 2024 | 8531 | 1.890 |
Why?
|
| Electrocardiography | 51 | 2022 | 6409 | 1.790 |
Why?
|
| Genome-Wide Association Study | 75 | 2024 | 12790 | 1.690 |
Why?
|
| Genetic Predisposition to Disease | 61 | 2024 | 18063 | 1.310 |
Why?
|
| Heart Conduction System | 17 | 2019 | 1008 | 1.300 |
Why?
|
| Atrial Natriuretic Factor | 10 | 2018 | 350 | 1.280 |
Why?
|
| Genetic Loci | 22 | 2020 | 2629 | 1.230 |
Why?
|
| Genetic Variation | 38 | 2021 | 6611 | 1.230 |
Why?
|
| Hypertension | 37 | 2024 | 8615 | 0.890 |
Why?
|
| Genome, Human | 22 | 2022 | 4441 | 0.800 |
Why?
|
| Genotype | 49 | 2021 | 13035 | 0.780 |
Why?
|
| Heart Rate | 13 | 2023 | 4209 | 0.770 |
Why?
|
| Cardiomyopathies | 4 | 2020 | 2057 | 0.760 |
Why?
|
| Gene Frequency | 21 | 2022 | 3621 | 0.690 |
Why?
|
| Shock, Cardiogenic | 3 | 2022 | 709 | 0.690 |
Why?
|
| Natriuretic Peptides | 5 | 2016 | 156 | 0.670 |
Why?
|
| Cardiovascular Diseases | 28 | 2023 | 15645 | 0.630 |
Why?
|
| Genetic Linkage | 7 | 2007 | 2342 | 0.630 |
Why?
|
| Adaptor Proteins, Signal Transducing | 16 | 2021 | 2902 | 0.620 |
Why?
|
| Atrial Fibrillation | 21 | 2023 | 5180 | 0.580 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 6 | 2010 | 72 | 0.580 |
Why?
|
| Chromosomes, Human, Pair 9 | 5 | 2019 | 534 | 0.550 |
Why?
|
| Quantitative Trait Loci | 14 | 2020 | 2131 | 0.550 |
Why?
|
| Sodium Channels | 5 | 2011 | 339 | 0.540 |
Why?
|
| Torsades de Pointes | 3 | 2019 | 78 | 0.540 |
Why?
|
| Chromosome Mapping | 10 | 2022 | 4616 | 0.530 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2019 | 308 | 0.520 |
Why?
|
| Coronary Artery Disease | 12 | 2020 | 6573 | 0.520 |
Why?
|
| Natriuretic Peptide, Brain | 11 | 2016 | 1749 | 0.500 |
Why?
|
| Multifactorial Inheritance | 4 | 2024 | 1422 | 0.490 |
Why?
|
| Potassium Channels, Voltage-Gated | 3 | 2010 | 141 | 0.480 |
Why?
|
| Quantitative Trait, Heritable | 6 | 2013 | 539 | 0.470 |
Why?
|
| Muscle Proteins | 6 | 2020 | 1160 | 0.450 |
Why?
|
| Myocytes, Cardiac | 5 | 2018 | 1672 | 0.440 |
Why?
|
| KCNQ1 Potassium Channel | 3 | 2010 | 103 | 0.440 |
Why?
|
| Chest Pain | 1 | 2020 | 1101 | 0.430 |
Why?
|
| Alleles | 23 | 2020 | 6893 | 0.410 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2017 | 843 | 0.390 |
Why?
|
| Humans | 221 | 2024 | 767040 | 0.390 |
Why?
|
| Genetic Markers | 9 | 2012 | 2602 | 0.380 |
Why?
|
| Finland | 11 | 2015 | 608 | 0.380 |
Why?
|
| Male | 151 | 2024 | 364203 | 0.380 |
Why?
|
| Female | 154 | 2024 | 396660 | 0.370 |
Why?
|
| Middle Aged | 124 | 2024 | 223233 | 0.370 |
Why?
|
| Vascular Diseases | 1 | 2019 | 1161 | 0.360 |
Why?
|
| Linkage Disequilibrium | 12 | 2022 | 1996 | 0.360 |
Why?
|
| Risk Factors | 60 | 2024 | 74886 | 0.360 |
Why?
|
| Phenotype | 31 | 2022 | 16718 | 0.340 |
Why?
|
| Myocardium | 7 | 2021 | 4765 | 0.340 |
Why?
|
| Calcium Signaling | 1 | 2014 | 736 | 0.330 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2011 | 856 | 0.330 |
Why?
|
| Cholesterol, LDL | 6 | 2012 | 2392 | 0.320 |
Why?
|
| Digoxin | 2 | 2021 | 246 | 0.310 |
Why?
|
| Renin | 3 | 2008 | 647 | 0.310 |
Why?
|
| Heart Failure | 12 | 2022 | 11877 | 0.310 |
Why?
|
| Pharmacogenetics | 4 | 2017 | 682 | 0.300 |
Why?
|
| Aged | 85 | 2024 | 171319 | 0.290 |
Why?
|
| Myocardial Infarction | 9 | 2019 | 11513 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 4 | 5 | 2012 | 377 | 0.290 |
Why?
|
| Coronary Disease | 5 | 2019 | 5914 | 0.280 |
Why?
|
| Cohort Studies | 47 | 2017 | 41718 | 0.280 |
Why?
|
| Hydroxychloroquine | 1 | 2011 | 427 | 0.270 |
Why?
|
| Adult | 78 | 2024 | 223317 | 0.270 |
Why?
|
| MicroRNAs | 4 | 2018 | 3792 | 0.270 |
Why?
|
| Genetic Association Studies | 8 | 2020 | 2744 | 0.260 |
Why?
|
| Polymorphism, Genetic | 7 | 2013 | 4247 | 0.260 |
Why?
|
| Diastole | 6 | 2014 | 784 | 0.260 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3112 | 0.250 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3234 | 0.250 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2019 | 773 | 0.250 |
Why?
|
| Haplotypes | 11 | 2022 | 2722 | 0.240 |
Why?
|
| Case-Control Studies | 24 | 2020 | 22254 | 0.240 |
Why?
|
| Connexin 43 | 2 | 2018 | 202 | 0.240 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 4 | 2019 | 42 | 0.240 |
Why?
|
| Systole | 5 | 2014 | 935 | 0.240 |
Why?
|
| Prehypertension | 2 | 2015 | 63 | 0.230 |
Why?
|
| Heart | 6 | 2022 | 4429 | 0.230 |
Why?
|
| Cholesterol, HDL | 5 | 2012 | 1816 | 0.230 |
Why?
|
| Rest | 3 | 2015 | 941 | 0.220 |
Why?
|
| Arteries | 5 | 2015 | 1123 | 0.210 |
Why?
|
| Heart Diseases | 3 | 2014 | 2817 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2008 | 640 | 0.210 |
Why?
|
| Peptide Fragments | 8 | 2016 | 5141 | 0.210 |
Why?
|
| Body Height | 2 | 2022 | 1565 | 0.200 |
Why?
|
| Aldosterone | 1 | 2007 | 881 | 0.190 |
Why?
|
| Risk Assessment | 15 | 2019 | 24299 | 0.190 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2016 | 429 | 0.190 |
Why?
|
| Mendelian Randomization Analysis | 5 | 2023 | 1040 | 0.190 |
Why?
|
| Calcium Channel Blockers | 3 | 2009 | 688 | 0.190 |
Why?
|
| Heart Transplantation | 3 | 2024 | 3305 | 0.190 |
Why?
|
| Antirheumatic Agents | 1 | 2011 | 1379 | 0.180 |
Why?
|
| Sarcomeres | 2 | 2015 | 379 | 0.180 |
Why?
|
| Meta-Analysis as Topic | 9 | 2012 | 1364 | 0.180 |
Why?
|
| Cholecalciferol | 2 | 2015 | 558 | 0.170 |
Why?
|
| Cardiotonic Agents | 2 | 2021 | 540 | 0.170 |
Why?
|
| Triglycerides | 4 | 2016 | 2444 | 0.170 |
Why?
|
| Sodium Chloride | 4 | 2016 | 580 | 0.170 |
Why?
|
| Heart Ventricles | 3 | 2018 | 3837 | 0.170 |
Why?
|
| Sotalol | 1 | 2019 | 47 | 0.170 |
Why?
|
| Phenethylamines | 1 | 2019 | 95 | 0.170 |
Why?
|
| Vitamins | 3 | 2021 | 1639 | 0.170 |
Why?
|
| Myocardial Ischemia | 1 | 2010 | 2131 | 0.160 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2012 | 144 | 0.160 |
Why?
|
| Incidence | 15 | 2024 | 21526 | 0.160 |
Why?
|
| Connective Tissue Diseases | 1 | 2022 | 285 | 0.160 |
Why?
|
| Aged, 80 and over | 26 | 2021 | 59548 | 0.160 |
Why?
|
| Cyclic GMP | 2 | 2018 | 394 | 0.160 |
Why?
|
| Follow-Up Studies | 19 | 2021 | 39317 | 0.160 |
Why?
|
| Proportional Hazards Models | 16 | 2019 | 12536 | 0.160 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2022 | 621 | 0.160 |
Why?
|
| Introns | 5 | 2018 | 965 | 0.160 |
Why?
|
| Guanylate Cyclase | 1 | 2019 | 206 | 0.150 |
Why?
|
| Stroke | 6 | 2017 | 9746 | 0.150 |
Why?
|
| Founder Effect | 2 | 2009 | 185 | 0.150 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2019 | 511 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2018 | 3797 | 0.150 |
Why?
|
| Tachycardia | 1 | 2020 | 598 | 0.150 |
Why?
|
| Exanthema | 1 | 2022 | 502 | 0.150 |
Why?
|
| Protein Kinase C-alpha | 1 | 2018 | 113 | 0.150 |
Why?
|
| Insulin Resistance | 6 | 2021 | 3986 | 0.140 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2017 | 78 | 0.140 |
Why?
|
| Prospective Studies | 21 | 2021 | 54886 | 0.140 |
Why?
|
| Vitamin D Deficiency | 3 | 2015 | 1389 | 0.140 |
Why?
|
| Glomerular Filtration Rate | 2 | 2024 | 2227 | 0.140 |
Why?
|
| Antihypertensive Agents | 3 | 2018 | 2030 | 0.140 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2016 | 300 | 0.130 |
Why?
|
| Brachial Artery | 3 | 2007 | 373 | 0.130 |
Why?
|
| Linear Models | 6 | 2021 | 5875 | 0.130 |
Why?
|
| Research Design | 4 | 2022 | 6210 | 0.130 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2022 | 562 | 0.130 |
Why?
|
| Ventricular Remodeling | 3 | 2022 | 1281 | 0.130 |
Why?
|
| Ion Channel Gating | 1 | 2018 | 428 | 0.130 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 2252 | 0.130 |
Why?
|
| Echocardiography | 3 | 2021 | 5042 | 0.130 |
Why?
|
| Angiopoietins | 1 | 2016 | 86 | 0.130 |
Why?
|
| Magnesium | 1 | 2019 | 815 | 0.130 |
Why?
|
| Aging | 4 | 2017 | 8729 | 0.130 |
Why?
|
| Lipoprotein Lipase | 1 | 2016 | 133 | 0.130 |
Why?
|
| Longitudinal Studies | 11 | 2021 | 14766 | 0.120 |
Why?
|
| Receptors, Cytokine | 1 | 2016 | 258 | 0.120 |
Why?
|
| Homeodomain Proteins | 4 | 2013 | 2429 | 0.120 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 527 | 0.120 |
Why?
|
| Potassium | 1 | 2019 | 1314 | 0.120 |
Why?
|
| Bundle-Branch Block | 2 | 2022 | 280 | 0.120 |
Why?
|
| Vitamin D | 2 | 2021 | 3312 | 0.120 |
Why?
|
| Hemodynamics | 2 | 2022 | 4186 | 0.120 |
Why?
|
| Chloride Channels | 1 | 2015 | 221 | 0.120 |
Why?
|
| Sweden | 6 | 2015 | 1382 | 0.120 |
Why?
|
| 1-Acylglycerophosphocholine O-Acyltransferase | 1 | 2014 | 9 | 0.110 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 1946 | 0.110 |
Why?
|
| Diagnosis, Differential | 4 | 2020 | 12986 | 0.110 |
Why?
|
| Europe | 4 | 2022 | 3432 | 0.110 |
Why?
|
| American Heart Association | 4 | 2022 | 1049 | 0.110 |
Why?
|
| Tissue Donors | 2 | 2024 | 2387 | 0.110 |
Why?
|
| Athletes | 2 | 2012 | 1162 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2019 | 1243 | 0.110 |
Why?
|
| Epigenomics | 2 | 2017 | 959 | 0.110 |
Why?
|
| Heart Arrest | 2 | 2015 | 1516 | 0.110 |
Why?
|
| Cardiomegaly | 1 | 2016 | 591 | 0.110 |
Why?
|
| SOX Transcription Factors | 1 | 2013 | 7 | 0.110 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2014 | 103 | 0.110 |
Why?
|
| Odds Ratio | 7 | 2019 | 9660 | 0.110 |
Why?
|
| Down-Regulation | 3 | 2016 | 2931 | 0.110 |
Why?
|
| rab3 GTP-Binding Proteins | 1 | 2013 | 29 | 0.110 |
Why?
|
| SOXD Transcription Factors | 1 | 2013 | 44 | 0.110 |
Why?
|
| Prevalence | 10 | 2015 | 15851 | 0.110 |
Why?
|
| Genetics, Population | 2 | 2018 | 943 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2007 | 706 | 0.110 |
Why?
|
| Multivariate Analysis | 10 | 2013 | 12069 | 0.110 |
Why?
|
| Sulfonamides | 2 | 2019 | 1982 | 0.110 |
Why?
|
| Genealogy and Heraldry | 1 | 2012 | 29 | 0.100 |
Why?
|
| Micronesia | 2 | 2010 | 44 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2013 | 76 | 0.100 |
Why?
|
| Methadone | 1 | 2015 | 317 | 0.100 |
Why?
|
| Fever | 1 | 2020 | 1605 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2016 | 1144 | 0.100 |
Why?
|
| Hypokalemia | 1 | 2013 | 152 | 0.100 |
Why?
|
| Adrenomedullin | 2 | 2009 | 85 | 0.100 |
Why?
|
| Protein Precursors | 3 | 2016 | 1134 | 0.100 |
Why?
|
| Carbolines | 1 | 2014 | 288 | 0.100 |
Why?
|
| Mutation, Missense | 4 | 2018 | 2592 | 0.100 |
Why?
|
| Dyspnea | 1 | 2020 | 1352 | 0.100 |
Why?
|
| Sodium, Dietary | 2 | 2013 | 426 | 0.100 |
Why?
|
| Neuregulin-1 | 1 | 2013 | 136 | 0.100 |
Why?
|
| Age of Onset | 2 | 2020 | 3344 | 0.100 |
Why?
|
| Blood Glucose | 5 | 2021 | 6421 | 0.100 |
Why?
|
| Population Groups | 2 | 2010 | 209 | 0.100 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2011 | 276 | 0.100 |
Why?
|
| Risk | 6 | 2013 | 9606 | 0.090 |
Why?
|
| Apolipoproteins | 1 | 2013 | 328 | 0.090 |
Why?
|
| Endonucleases | 1 | 2014 | 371 | 0.090 |
Why?
|
| Open Reading Frames | 2 | 2018 | 818 | 0.090 |
Why?
|
| Obesity | 5 | 2016 | 13085 | 0.090 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2011 | 20 | 0.090 |
Why?
|
| Weight Loss | 2 | 2015 | 2716 | 0.090 |
Why?
|
| Ventricular Function | 1 | 2013 | 404 | 0.090 |
Why?
|
| Hepatitis C, Chronic | 1 | 2019 | 1032 | 0.090 |
Why?
|
| Atherosclerosis | 4 | 2013 | 3418 | 0.090 |
Why?
|
| Health Records, Personal | 1 | 2012 | 126 | 0.090 |
Why?
|
| Database Management Systems | 1 | 2012 | 263 | 0.090 |
Why?
|
| Surgical Procedures, Operative | 1 | 2022 | 1931 | 0.090 |
Why?
|
| Anthropometry | 2 | 2013 | 1345 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 684 | 0.090 |
Why?
|
| Uromodulin | 1 | 2010 | 48 | 0.090 |
Why?
|
| Aortic Diseases | 1 | 2016 | 741 | 0.090 |
Why?
|
| Mutation | 9 | 2020 | 30211 | 0.090 |
Why?
|
| Sodium | 1 | 2016 | 1594 | 0.090 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 3934 | 0.090 |
Why?
|
| Potassium Channels | 1 | 2013 | 534 | 0.090 |
Why?
|
| Dietary Supplements | 2 | 2021 | 3446 | 0.090 |
Why?
|
| C-Reactive Protein | 5 | 2010 | 3851 | 0.090 |
Why?
|
| Quality Control | 2 | 2014 | 835 | 0.090 |
Why?
|
| Ventricular Fibrillation | 1 | 2013 | 538 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2011 | 313 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2013 | 2815 | 0.090 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2010 | 38 | 0.090 |
Why?
|
| Sex Factors | 9 | 2019 | 10622 | 0.080 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2011 | 224 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 7 | 2016 | 4780 | 0.080 |
Why?
|
| Phospholipase C delta | 1 | 2009 | 7 | 0.080 |
Why?
|
| Fibroblast Growth Factor 5 | 1 | 2009 | 9 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2011 | 216 | 0.080 |
Why?
|
| Zinc Fingers | 1 | 2012 | 577 | 0.080 |
Why?
|
| Pilot Projects | 4 | 2017 | 8732 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 1612 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 2006 | 0.080 |
Why?
|
| Aneurysm, Ruptured | 1 | 2015 | 455 | 0.080 |
Why?
|
| Cross-Sectional Studies | 9 | 2016 | 26325 | 0.080 |
Why?
|
| Hypopituitarism | 1 | 2011 | 253 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 705 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2013 | 12250 | 0.080 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2009 | 68 | 0.080 |
Why?
|
| Exercise Test | 2 | 2007 | 2188 | 0.080 |
Why?
|
| Mississippi | 1 | 2009 | 93 | 0.080 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 679 | 0.080 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2009 | 99 | 0.080 |
Why?
|
| Melphalan | 1 | 2010 | 421 | 0.080 |
Why?
|
| Hypotension, Orthostatic | 1 | 2012 | 258 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 1029 | 0.080 |
Why?
|
| Heart Murmurs | 1 | 2009 | 92 | 0.080 |
Why?
|
| Pneumonia | 1 | 2020 | 2159 | 0.080 |
Why?
|
| Time Factors | 8 | 2024 | 40154 | 0.080 |
Why?
|
| Dihydropyridines | 1 | 2008 | 67 | 0.080 |
Why?
|
| Animals | 18 | 2019 | 168965 | 0.080 |
Why?
|
| Predictive Value of Tests | 8 | 2015 | 15424 | 0.080 |
Why?
|
| DNA | 3 | 2013 | 7210 | 0.080 |
Why?
|
| Glycopeptides | 1 | 2010 | 225 | 0.080 |
Why?
|
| Disease Susceptibility | 4 | 2007 | 1791 | 0.080 |
Why?
|
| Verapamil | 1 | 2009 | 242 | 0.080 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2010 | 329 | 0.080 |
Why?
|
| Interleukins | 1 | 2013 | 796 | 0.080 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2015 | 707 | 0.070 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 373 | 0.070 |
Why?
|
| Receptors, Drug | 1 | 2008 | 156 | 0.070 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2008 | 106 | 0.070 |
Why?
|
| DNA-Binding Proteins | 4 | 2018 | 9612 | 0.070 |
Why?
|
| United States | 13 | 2022 | 72971 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2016 | 386 | 0.070 |
Why?
|
| Calcium | 2 | 2019 | 5792 | 0.070 |
Why?
|
| Gene Expression | 5 | 2020 | 7587 | 0.070 |
Why?
|
| Genomics | 3 | 2021 | 5924 | 0.070 |
Why?
|
| Genetics, Medical | 1 | 2010 | 334 | 0.070 |
Why?
|
| Pacemaker, Artificial | 2 | 2010 | 828 | 0.070 |
Why?
|
| Troponin | 1 | 2011 | 536 | 0.070 |
Why?
|
| Androgens | 2 | 2011 | 1281 | 0.070 |
Why?
|
| Atrioventricular Block | 1 | 2009 | 141 | 0.070 |
Why?
|
| Prognosis | 10 | 2021 | 29963 | 0.070 |
Why?
|
| Hypothermia, Induced | 1 | 2012 | 754 | 0.070 |
Why?
|
| Metabolomics | 2 | 2017 | 1675 | 0.070 |
Why?
|
| Placenta | 1 | 2016 | 1726 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2018 | 18989 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2019 | 3070 | 0.070 |
Why?
|
| Aortic Valve | 1 | 2016 | 1968 | 0.070 |
Why?
|
| Sulfonylurea Compounds | 1 | 2008 | 220 | 0.070 |
Why?
|
| Testosterone | 3 | 2011 | 2490 | 0.070 |
Why?
|
| Antiporters | 2 | 2018 | 275 | 0.070 |
Why?
|
| Cause of Death | 2 | 2015 | 3717 | 0.070 |
Why?
|
| Massachusetts | 6 | 2022 | 8890 | 0.070 |
Why?
|
| Gene Expression Regulation | 6 | 2016 | 11923 | 0.070 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2010 | 881 | 0.070 |
Why?
|
| Survival Analysis | 4 | 2015 | 10092 | 0.060 |
Why?
|
| Young Adult | 14 | 2021 | 59980 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2011 | 756 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2014 | 1806 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2007 | 411 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2006 | 175 | 0.060 |
Why?
|
| Drosophila | 1 | 2013 | 1509 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2015 | 1790 | 0.060 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 2021 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 2012 | 341 | 0.060 |
Why?
|
| Symporters | 1 | 2008 | 363 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2015 | 2594 | 0.060 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2015 | 1250 | 0.060 |
Why?
|
| Selection, Genetic | 2 | 2009 | 877 | 0.060 |
Why?
|
| Proteins | 2 | 2010 | 6001 | 0.060 |
Why?
|
| Homozygote | 3 | 2018 | 1774 | 0.060 |
Why?
|
| Double-Blind Method | 5 | 2021 | 12451 | 0.060 |
Why?
|
| RNA Interference | 1 | 2013 | 2829 | 0.060 |
Why?
|
| Sample Size | 2 | 2022 | 845 | 0.060 |
Why?
|
| Vasodilation | 2 | 2006 | 968 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 2007 | 4424 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 1081 | 0.060 |
Why?
|
| Proteomics | 2 | 2017 | 3913 | 0.060 |
Why?
|
| DNA Methylation | 2 | 2016 | 4426 | 0.060 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 1481 | 0.060 |
Why?
|
| COS Cells | 2 | 2018 | 1135 | 0.060 |
Why?
|
| Retrospective Studies | 8 | 2024 | 81659 | 0.060 |
Why?
|
| Treatment Outcome | 10 | 2024 | 65295 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2005 | 322 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3431 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2013 | 1705 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 1293 | 0.060 |
Why?
|
| Netherlands | 4 | 2009 | 2277 | 0.050 |
Why?
|
| Pandemics | 2 | 2020 | 8736 | 0.050 |
Why?
|
| Microfilament Proteins | 2 | 2020 | 1130 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2011 | 2605 | 0.050 |
Why?
|
| Psychotropic Drugs | 1 | 2009 | 881 | 0.050 |
Why?
|
| Outpatients | 1 | 2011 | 1600 | 0.050 |
Why?
|
| Genetic Testing | 4 | 2022 | 3591 | 0.050 |
Why?
|
| Sex Distribution | 3 | 2015 | 2276 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2015 | 2912 | 0.050 |
Why?
|
| Amyloidosis | 1 | 2010 | 876 | 0.050 |
Why?
|
| Body Mass Index | 7 | 2018 | 13048 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2021 | 10748 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2005 | 784 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 1752 | 0.050 |
Why?
|
| Blood Pressure Determination | 2 | 2016 | 646 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1160 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 2495 | 0.050 |
Why?
|
| India | 1 | 2009 | 2334 | 0.050 |
Why?
|
| Renal Replacement Therapy | 1 | 2024 | 281 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2008 | 1592 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2015 | 5345 | 0.050 |
Why?
|
| Intracranial Aneurysm | 1 | 2012 | 1271 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 1596 | 0.050 |
Why?
|
| Transcription Factors | 4 | 2018 | 12158 | 0.050 |
Why?
|
| Diabetes Mellitus | 2 | 2011 | 5886 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 10076 | 0.050 |
Why?
|
| ROC Curve | 4 | 2011 | 3618 | 0.050 |
Why?
|
| Adiposity | 1 | 2011 | 1894 | 0.050 |
Why?
|
| GATA5 Transcription Factor | 1 | 2020 | 18 | 0.050 |
Why?
|
| Brain Death | 1 | 2024 | 360 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2016 | 4280 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2017 | 8068 | 0.050 |
Why?
|
| Base Sequence | 2 | 2013 | 12414 | 0.050 |
Why?
|
| Phospholipase C beta | 1 | 2020 | 48 | 0.050 |
Why?
|
| Mortality | 2 | 2015 | 2909 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2009 | 2189 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 2004 | 581 | 0.040 |
Why?
|
| Echocardiography, Doppler | 2 | 2015 | 898 | 0.040 |
Why?
|
| Zebrafish | 3 | 2018 | 3036 | 0.040 |
Why?
|
| Drug Dosage Calculations | 1 | 2019 | 116 | 0.040 |
Why?
|
| Principal Component Analysis | 2 | 2013 | 950 | 0.040 |
Why?
|
| Age Distribution | 2 | 2015 | 2870 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 3837 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2887 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2698 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2020 | 376 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 20741 | 0.040 |
Why?
|
| Logistic Models | 2 | 2010 | 13284 | 0.040 |
Why?
|
| Suburban Population | 2 | 2009 | 54 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 2160 | 0.040 |
Why?
|
| Reference Values | 3 | 2013 | 4918 | 0.040 |
Why?
|
| Endophenotypes | 1 | 2020 | 258 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10254 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 17608 | 0.040 |
Why?
|
| Stroke Volume | 3 | 2022 | 5618 | 0.040 |
Why?
|
| Bradycardia | 1 | 2019 | 305 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2015 | 4881 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2022 | 1824 | 0.040 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2017 | 141 | 0.040 |
Why?
|
| Pyrrolidines | 1 | 2019 | 339 | 0.040 |
Why?
|
| Adolescent | 8 | 2021 | 89046 | 0.040 |
Why?
|
| Quinoxalines | 1 | 2019 | 297 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2018 | 318 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2015 | 2920 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 1011 | 0.030 |
Why?
|
| Mice | 7 | 2018 | 81912 | 0.030 |
Why?
|
| Family Health | 2 | 2015 | 1254 | 0.030 |
Why?
|
| Kidney Tubules | 1 | 2018 | 454 | 0.030 |
Why?
|
| Immunoassay | 2 | 2011 | 744 | 0.030 |
Why?
|
| Poisoning | 1 | 2018 | 253 | 0.030 |
Why?
|
| Amino Acid Substitution | 2 | 2013 | 1743 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2018 | 446 | 0.030 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2018 | 320 | 0.030 |
Why?
|
| Pulsatile Flow | 2 | 2007 | 318 | 0.030 |
Why?
|
| Mass Screening | 1 | 2012 | 5456 | 0.030 |
Why?
|
| Age Factors | 4 | 2019 | 18401 | 0.030 |
Why?
|
| Tissue and Organ Procurement | 1 | 2024 | 987 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2019 | 588 | 0.030 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 262 | 0.030 |
Why?
|
| Confusion | 1 | 2018 | 278 | 0.030 |
Why?
|
| Life Style | 2 | 2018 | 3931 | 0.030 |
Why?
|
| Computational Biology | 3 | 2014 | 3567 | 0.030 |
Why?
|
| Spain | 1 | 2016 | 483 | 0.030 |
Why?
|
| Epidemiologic Methods | 2 | 2012 | 1326 | 0.030 |
Why?
|
| Nausea | 1 | 2018 | 682 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 787 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2016 | 378 | 0.030 |
Why?
|
| Monitoring, Physiologic | 2 | 2015 | 1794 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2010 | 3464 | 0.030 |
Why?
|
| Vomiting | 1 | 2018 | 655 | 0.030 |
Why?
|
| Smoking | 4 | 2019 | 9081 | 0.030 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2016 | 291 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2019 | 778 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 1150 | 0.030 |
Why?
|
| Hyperemia | 2 | 2006 | 223 | 0.030 |
Why?
|
| Lipids | 2 | 2021 | 3322 | 0.030 |
Why?
|
| Exercise | 1 | 2011 | 5954 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 30238 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2013 | 6977 | 0.030 |
Why?
|
| Benzimidazoles | 1 | 2019 | 862 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2018 | 1526 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2022 | 1944 | 0.030 |
Why?
|
| Databases, Genetic | 2 | 2011 | 1758 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 751 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3702 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 93 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2019 | 963 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 15925 | 0.030 |
Why?
|
| Heterozygote | 2 | 2012 | 2794 | 0.030 |
Why?
|
| Myocarditis | 1 | 2021 | 802 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2009 | 6282 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2013 | 127 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7435 | 0.030 |
Why?
|
| Kidney | 2 | 2024 | 7063 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2019 | 2086 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2007 | 1479 | 0.030 |
Why?
|
| Oregon | 1 | 2013 | 148 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2013 | 174 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2018 | 838 | 0.030 |
Why?
|
| Myofibrils | 1 | 2013 | 143 | 0.030 |
Why?
|
| GC Rich Sequence | 1 | 2012 | 19 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2013 | 316 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5716 | 0.020 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2011 | 17 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2019 | 1342 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 321 | 0.020 |
Why?
|
| Hypoxia, Brain | 1 | 2012 | 139 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2011 | 6331 | 0.020 |
Why?
|
| Louisiana | 1 | 2011 | 104 | 0.020 |
Why?
|
| Transdermal Patch | 1 | 2011 | 51 | 0.020 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2011 | 43 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2013 | 614 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1604 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 1320 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12823 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2011 | 52 | 0.020 |
Why?
|
| Lentivirus | 1 | 2014 | 518 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 515 | 0.020 |
Why?
|
| Cell Line | 2 | 2018 | 15567 | 0.020 |
Why?
|
| Angiotensinogen | 1 | 2011 | 161 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2016 | 1141 | 0.020 |
Why?
|
| Atrioventricular Node | 1 | 2011 | 180 | 0.020 |
Why?
|
| Base Pairing | 1 | 2010 | 139 | 0.020 |
Why?
|
| Transfection | 1 | 2018 | 5753 | 0.020 |
Why?
|
| Boston | 2 | 2014 | 9360 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2014 | 966 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3434 | 0.020 |
Why?
|
| Lipase | 1 | 2012 | 320 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 2227 | 0.020 |
Why?
|
| Comorbidity | 2 | 2016 | 10582 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2011 | 325 | 0.020 |
Why?
|
| Asia | 1 | 2011 | 629 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 6513 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2018 | 4143 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2011 | 715 | 0.020 |
Why?
|
| Pedigree | 2 | 2009 | 4539 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 2001 | 0.020 |
Why?
|
| Pacific Islands | 1 | 2009 | 52 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 9532 | 0.020 |
Why?
|
| Markov Chains | 1 | 2013 | 976 | 0.020 |
Why?
|
| Africa | 1 | 2011 | 725 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 582 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2011 | 344 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2013 | 723 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2010 | 415 | 0.020 |
Why?
|
| Telemetry | 1 | 2010 | 201 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 2011 | 560 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 5796 | 0.020 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2011 | 553 | 0.020 |
Why?
|
| Longevity | 1 | 2016 | 1083 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2010 | 437 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 800 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2011 | 402 | 0.020 |
Why?
|
| California | 1 | 2012 | 1439 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2015 | 1480 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2011 | 471 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 1562 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2009 | 370 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4210 | 0.020 |
Why?
|
| Inpatients | 1 | 2019 | 2563 | 0.020 |
Why?
|
| Alanine | 1 | 2010 | 613 | 0.020 |
Why?
|
| Insulin | 2 | 2014 | 6602 | 0.020 |
Why?
|
| Cystatin C | 1 | 2009 | 272 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2018 | 1942 | 0.020 |
Why?
|
| Disease Management | 1 | 2018 | 2531 | 0.020 |
Why?
|
| Adult Children | 1 | 2008 | 104 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2012 | 701 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3804 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2016 | 12793 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2014 | 898 | 0.020 |
Why?
|
| Premenopause | 1 | 2011 | 1039 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 310 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 505 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2012 | 978 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15824 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 2616 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2008 | 350 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1505 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2020 | 4925 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3760 | 0.020 |
Why?
|
| Genomic Imprinting | 1 | 2008 | 326 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2015 | 820 | 0.020 |
Why?
|
| Delirium | 1 | 2018 | 1698 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 624 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 208 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2008 | 451 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 1516 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2015 | 2252 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 279 | 0.020 |
Why?
|
| Manometry | 1 | 2008 | 458 | 0.020 |
Why?
|
| Albumins | 1 | 2008 | 577 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2010 | 2118 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2009 | 834 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2021 | 4854 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2677 | 0.020 |
Why?
|
| Elasticity | 1 | 2007 | 654 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 2493 | 0.010 |
Why?
|
| Syndrome | 1 | 2011 | 3271 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 5499 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 4114 | 0.010 |
Why?
|
| Estrogens | 1 | 2011 | 1536 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3667 | 0.010 |
Why?
|
| Models, Animal | 1 | 2010 | 2121 | 0.010 |
Why?
|
| Calcinosis | 1 | 2013 | 1481 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 2047 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2013 | 2856 | 0.010 |
Why?
|
| Vasculitis | 1 | 2008 | 526 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 2004 | 214 | 0.010 |
Why?
|
| Diet | 2 | 2011 | 8089 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2013 | 5388 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2004 | 570 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 1337 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6215 | 0.010 |
Why?
|
| Fasting | 1 | 2009 | 1607 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2007 | 827 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2008 | 806 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2007 | 934 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2009 | 2721 | 0.010 |
Why?
|
| Creatinine | 1 | 2008 | 1916 | 0.010 |
Why?
|
| Probability | 1 | 2008 | 2476 | 0.010 |
Why?
|
| Postmenopause | 1 | 2011 | 2518 | 0.010 |
Why?
|
| Body Weight | 1 | 2013 | 4627 | 0.010 |
Why?
|
| Drug Discovery | 1 | 2010 | 1068 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 20169 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2004 | 959 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 1374 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2016 | 23621 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 2007 | 849 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 582 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2015 | 42606 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2011 | 2099 | 0.010 |
Why?
|
| Rats | 1 | 2016 | 23713 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2013 | 2954 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4052 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 2299 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2013 | 6260 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 3599 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 3828 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9551 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4256 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2012 | 5098 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 3445 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 5537 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 13411 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2009 | 6000 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 3108 | 0.010 |
Why?
|
| Child | 2 | 2015 | 80771 | 0.010 |
Why?
|
| Algorithms | 1 | 2014 | 14098 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 13646 | 0.010 |
Why?
|
| Liver | 1 | 2008 | 7578 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 10393 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 10869 | 0.000 |
Why?
|
| Neoplasms | 1 | 2011 | 22350 | 0.000 |
Why?
|